E-LIB Suche - Ergebnisse für: Léa Hoisnard

1

Persistence and safety of anti-TNF biosimilars versus origi..:

Jourdain, Hugo ; Hoisnard, Léa ; Sbidian, Emilie.
RMD Open. 10 (2024) 1 - p. e003531 , 2024

Link: https://doi.org/10.1136/..

2

Risk of Gastrointestinal Perforation in Patients With Rheum..:

Hoisnard, Lea ; Meyer, Antoine ; Dray‐Spira, Rosemary...
Arthritis & Rheumatology. , 2024

Link: https://doi.org/10.1002/..

3

Validation of an Algorithm to Identify Epidermal Necrolysis..:

Bettuzzi, Thomas ; Hoisnard, Léa ; Beytout, Quentin..
Journal of Investigative Dermatology. 144 (2024) 3 - p. 708-710.e7 , 2024

Link: https://doi.org/10.1016/..

4

Prolonged use of nomegestrol acetate and risk of intracrani..:

Nguyen, Pierre ; Roland, Noémie ; Neumann, Anke...
The Lancet Regional Health - Europe. 42 (2024) - p. 100928 , 2024

Link: https://doi.org/10.1016/..

5

Use of progestogens and the risk of intracranial meningioma..:

Roland, Noémie ; Neumann, Anke ; Hoisnard, Léa...
BMJ. , 2024

Link: https://doi.org/10.1136/..

6

Severe Hypersensitivity Reactions at Biosimilar versus Orig..:

Jourdain, Hugo ; Hoisnard, Léa ; Sbidian, Emilie.
BioDrugs. 37 (2023) 3 - p. 397-407 , 2023

Link: https://doi.org/10.1007/..

7

32696 Adverse events associated with JAK inhibitors in 126,..:

Hoisnard, Lea ; Maury, Pr Sébastien ; Mahévas, Pr Matthieu...
Journal of the American Academy of Dermatology. 87 (2022) 3 - p. AB137 , 2022

Link: https://doi.org/10.1016/..

8

Adverse events associated with JAK inhibitors in 126,815 re..:

Hoisnard, Léa ; Lebrun-Vignes, Bénédicte ; Maury, Sébastien...
Scientific Reports. 12 (2022) 1 - p. , 2022

Link: https://doi.org/10.1038/..

9

Three-Year Outcomes in Kidney Transplant Recipients Switche..:

Morel, Antoine ; Hoisnard, Léa ; Dudreuilh, Caroline...
Transplant International. 35 (2022) - p. , 2022

Link: https://doi.org/10.3389/..

10

TNF-alpha inhibitors biosimilar use in France: a nationwide..:

Jourdain, Hugo ; Hoisnard, Léa ; Sbidian, Emilie.
Scientific Reports. 12 (2022) 1 - p. , 2022

Link: https://doi.org/10.1038/..

11

Risk of intracranial meningioma with three potent progestog..:

Hoisnard, Léa ; Laanani, Moussa ; Passeri, Thibault...
European Journal of Neurology. 29 (2022) 9 - p. 2801-2809 , 2022

Link: https://doi.org/10.1111/..

12

Long-term persistence of second-line biologics in psoriatic..:

Pina Vegas, Laura ; Hoisnard, Léa ; Bastard, Léa..
RMD Open. 8 (2022) 2 - p. e002681 , 2022

Link: https://doi.org/10.1136/..

13

Do older adults know the purpose of their medications? A su..:

Hoisnard, Léa ; Santos-Eggimann, Brigitte ; Chauvin, Pauline..
European Journal of Clinical Pharmacology. 75 (2018) 2 - p. 255-263 , 2018

Link: https://doi.org/10.1007/..

14

Adverse events associated with JAK inhibitors in 126,815 re..:

Léa Hoisnard ; Bénédicte Lebrun-Vignes ; Sébastien Maury...
https://doi.org/10.1038/s41598-022-10777-w. , 2022

Link: https://doi.org/10.1038/..

15

Long-term persistence of second-line biologics in psoriatic..:

Pascal Claudepierre ; Léa Bastard ; Lea Hoisnard..
https://rmdopen.bmj.com/content/8/2/e002681.full. , 2022

Link: https://doi.org/10.1136/..